Cargando…

Abstract 14 Omidubicel-Onlv: Robustness of the Manufacturing Process

INTRODUCTION: Omidubicel-onlv is a nicotinamide (NAM) -modified allogeneic hematopoietic progenitor cell therapy derived from cord blood. NAM expansion increases the number of stem and progenitor cells, inhibits differentiation, and potentiates migration, bone marrow homing, and engraftment efficien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landau, Efrat, Goudsmid-Rosenheimer, Noga, Hasson, Nira, Bengaiev, Roman, Guttman, Miri, Yaacobov, Liat, Nuriel, Yonatan, Geffen, Yona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Cord Blood Collection, Manufacturing and Cell Engineering
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476960/ http://dx.doi.org/10.1093/stcltm/szad047.015

Ejemplares similares

Abstract 24 Improving Cord Blood Unit Selection and Optimizing Manufacturing of a Unique Cord Blood-Derived Product (DUOC-01)
por: Ozamiz, April, et al.
Publicado: (2022)

Abstract 22 CellStor Transfer Freezing Bag: Reliable Closed System for Complex Cord Blood Sample Processing and CD34+ Hematopoietic Stem Cell Cryopreservation
por: Kasthuri, Srikumar, et al.
Publicado: (2022)

Abstract 21 High-Throughput Blood Separation System for CD34+ Cell Isolation
por: Fedenko, Shannon, et al.
Publicado: (2022)

Abstract 20 A Rapid and Sensitive IL-3-Based Assay Reveals How Various Pre-Processing Conditions Affect the Potency of Hematopoietic Stem Cells in Fresh Cord Blood Units
por: Dumont, Nellie, et al.
Publicado: (2022)

Abstract 19 Cleveland Cord Blood Center (CCBC) Best Practices Throughout the COVID-19 Pandemic and How It Impacted Collection of Cord Blood Units
por: Bobik-Kurz, Kathy, et al.
Publicado: (2022)

Abstract 23 A First Insight into the Validity of Post-Thaw Cell Recovery, Viability, and Potency Over Time
por: Liu, Lin, et al.
Publicado: (2022)

Abstract 13 Long-Term Stability of Dus Cord Blood Units After >29 Years of Cryopreservation: Follow-Up Data from the José Carreras Cord Blood Bank
por: Liedtke, Stefanie, et al.
Publicado: (2023)

Abstract 12 Evaluating the Properties of the Donor to Determine the Quality of Cord Blood
por: Do, Duy, et al.
Publicado: (2023)

Abstract 16 Insights into Highly Engraftable Hematopoietic Cells from 27-Year Cryopreserved Umbilical Cord Blood
por: Broxmeyer, Hal, et al.
Publicado: (2023)

Abstract 15 A State-Run Public Cord Blood Collection Program
por: Wilt, Kristen, et al.
Publicado: (2023)

Abstract 17 Umbilical Cord Blood Collection. How Do Different Factors Affect CD45 Cell Viability in Our Experience?
por: Gonel, Lorena, et al.
Publicado: (2023)

Abstract 19 CD34+ Cell Isolation from Cord Blood: A Novel Option for Faster, More Consistent Outcomes
por: Fedenko, Shannon, et al.
Publicado: (2023)

Abstract 18 Leveraging the BMDI Cord Blood Bank to Create a GMP-Compliant Cord Blood (CB)–Derived Induced Pluripotent Stem Cell (iPSC) Master Cell Bank (MCB) for Potential Allogeneic Therapies
por: Tian, Pei, et al.
Publicado: (2023)

White Matter Tract Changes Associated with Clinical Improvement in an Open‐Label Trial Assessing Autologous Umbilical Cord Blood for Treatment of Young Children with Autism
por: Carpenter, Kimberly L. H., et al.
Publicado: (2019)

Umbilical Cord Blood Units Cryopreserved in the Public Cord Blood Bank: A Breakthrough in iPSC Haplobanking?
por: Roh, Eun Youn, et al.
Publicado: (2020)

Human cord blood‐derived regulatory T‐cell therapy modulates the central and peripheral immune response after traumatic brain injury
por: Caplan, Henry W., et al.
Publicado: (2020)

Autologous cord blood cell infusion in preterm neonates safely reduces respiratory support duration and potentially preterm complications
por: Ren, Zhuxiao, et al.
Publicado: (2019)

Human Cord Blood‐Derived Unrestricted Somatic Stem Cell Infusion Improves Neurobehavioral Outcome in a Rabbit Model of Intraventricular Hemorrhage
por: Vinukonda, Govindaiah, et al.
Publicado: (2019)

A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients
por: Lu, Wenyi, et al.
Publicado: (2022)

Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow Donor Association Cord Blood Working Group
por: Jöris, Monique, et al.
Publicado: (2020)

Transcriptional and functional characterization of neonatal circulating Innate Lymphoid Cells
por: Bennstein, Sabrina Bianca, et al.
Publicado: (2021)

Contamination Rate of Cryopreserved Umbilical Cord Blood Is Inversely Correlated with Volume of Sample Collected and Is also Dependent on Delivery Mode
por: Reuther, Susanne, et al.
Publicado: (2022)

Transient Inhibition of the JNK Pathway Promotes Human Hematopoietic Stem Cell Quiescence and Engraftment
por: Xie, Huangfan, et al.
Publicado: (2022)

Augmented Production of Platelets From Cord Blood With Euchromatic Histone Lysine Methyltransferase Inhibition
por: Liu, Yiying, et al.
Publicado: (2022)

Unrelated Donor Cord Blood Transplantation in Children: Lessons Learned Over 3 Decades
por: Kurtzberg, Joanne, et al.
Publicado: (2023)

Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications
por: Abberton, Keren M, et al.
Publicado: (2022)

The Antioxidant TEMPOL Protects Human Hematopoietic Stem Cells From Culture-Mediated Loss of Functions
por: Henry, Elia, et al.
Publicado: (2023)

Abstract 2 Results of an Open Label Expanded Access Study of Omidubicel-onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies
por: Horwitz, Mitchell, et al.
Publicado: (2023)

Performance characteristics of a novel blood bag in-line closure device and subsequent product quality assessment
por: Serrano, Katherine, et al.
Publicado: (2010)

Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors
por: Wong, Horas Tze Hoo, et al.
Publicado: (2015)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Estimation of the number of blood donors during the COVID‐19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission
por: Yuan, Zhaohu, et al.
Publicado: (2020)

Deferral rate variability in blood donor eligibility assessment
por: de Kort, Wim, et al.
Publicado: (2018)

Ensuring HLA‐matched platelet support requires an ethnic diverse donor population
por: Kreuger, Aukje L., et al.
Publicado: (2020)

First results of a ferritin‐based blood donor deferral policy in the Netherlands
por: Vinkenoog, Marieke, et al.
Publicado: (2020)

Determinants of blood donation willingness in the European Union: a cross‐country perspective on perceived transfusion safety, concerns, and incentives
por: Huis in ‘t Veld, Elisabeth M.J., et al.
Publicado: (2019)

Prediction paradigm involving time series applied to total blood issues data from England
por: Nandi, Anita K., et al.
Publicado: (2020)

Do deferred donors continue their donations? A large‐scale register study on whole blood donor return in the Netherlands
por: Spekman, Marloes L.C., et al.
Publicado: (2019)

Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy
por: Spekman, Marloes L.C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ocov0n8k2t0ddo487bl7h0839n